E-LIB Suche - Ergebnisse für: Feragalli, B

1

Pycnogenol® Supplementation Prevents Recurrent Urinary Trac..:

Ledda, A. ; Hu, S. ; Cesarone, M. R....
Evidence-Based Complementary and Alternative Medicine. 2021 (2021) - p. 1-8 , 2021

Link: https://doi.org/10.1155/..

2

Structured reporting of chest CT in COVID-19 pneumonia: a c..:

Neri, E. ; Coppola, F. ; Larici, A. R....
Insights into Imaging. 11 (2020) 1 - p. , 2020

Link: https://doi.org/10.1186/..

3

Pycnogenol® Supplementation Improves Health Risk Factors in..:

Belcaro, G. ; Cornelli, U. ; Luzzi, R....
Phytotherapy Research. 27 (2013) 10 - p. 1572-1578 , 2013

Link: https://doi.org/10.1002/..

4

Underestimation of Atypical Lobular Hyperplasia and Lobular..:

Gatta, G. ; Di Grezia, G. ; Ancona, A....
European Journal of Inflammation. 11 (2013) 3 - p. 825-835 , 2013

Link: https://doi.org/10.1177/..

5

Radiographic evaluation of mediastinal lines as a diagnosti..:

Feragalli, B. ; Mantini, C. ; Patea, R. L....
La radiologia medica. 116 (2011) 4 - p. 532-547 , 2011

Link: https://doi.org/10.1007/..

6

TC ad alta risoluzione nelle infezioni polmonari da micobat..:

Polverosi, R. ; Guarise, A. ; Balestro, E....
La radiologia medica. 115 (2009) 2 - p. 191-204 , 2009

Link: https://doi.org/10.1007/..

7

Prevalence of Ponticulus Posticus and Migraine in 220 Ortho..:

Macri' M ; Rendina F ; Feragalli B..
info:eu-repo/semantics/altIdentifier/pmid/36979162. , 2023

Link: https://hdl.handle.net/1..

8

Structured reporting of chest CT in COVID-19 pneumonia: a c..:

Neri, E ; Coppola, F ; Larici, A. R...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422456/. , 2020

Link: http://www.ncbi.nlm.nih...

9

Artificial Saliva in Diabetic Xerostomia (ASDIX): Double Bl..:

Sinjari, B ; Feragalli, B ; Cornelli, U...
info:eu-repo/semantics/altIdentifier/pmid/32664567. , 2020

Link: http://hdl.handle.net/11..

10

Supplementary prevention and management of asthma with quer..:

Cesarone M. R ; Belcaro G ; Hu S...
info:eu-repo/semantics/altIdentifier/pmid/31578841. , 2019

Link: http://hdl.handle.net/11..

11

Structured reporting for fibrosing lung disease: a model sh..:

Sverzellati N ; Odone A ; Silva M...
info:eu-repo/semantics/altIdentifier/pmid/29230680. , 2018

Link: http://hdl.handle.net/11..

12

Structured reporting for fibrosing lung disease: a model sh..:

Sverzellati N ; Odone A ; Silva M...
info:eu-repo/semantics/altIdentifier/wos/WOS:000427504700001. , 2018

Link: http://hdl.handle.net/24..

13

Effects of a curcumin-based supplementation in asymptomatic..:

Riva, A ; Togni, S ; Giacomelli, L...
info:eu-repo/semantics/altIdentifier/pmid/28429336. , 2017

Link: http://hdl.handle.net/11..

14

Effectiveness of a novel boswellic acids delivery form (Cas..:

Feragalli, B ; Ippolito, E ; Dugall, M...
info:eu-repo/semantics/altIdentifier/pmid/29131239. , 2017

Link: http://hdl.handle.net/11..

15

A natural pharma standard supplement formulation to control..:

Ledda, A ; Belcaro, G ; Dugall, M...
info:eu-repo/semantics/altIdentifier/pmid/29028078. , 2017

Link: http://hdl.handle.net/11..